To hear about similar clinical trials, please enter your email below

Trial Title: Use of Bone Scintigraphy, CT and MRI in Breast Cancer

NCT ID: NCT00682253

Condition: Breast Neoplasms

Conditions: Official terms:
Breast Neoplasms

Conditions: Keywords:
SPECT/CT
MRI
Breast neoplasms

Study type: Observational

Overall status: Unknown status

Study design:

Time perspective: Prospective

Summary: A new imaging modality combining CT and tomographic bone scintigraphy (SPECT/CT) has enabled the combination of functional and anatomical imaging. Its use in cancer patients has not yet been evaluated or validated against a relative gold stand or clinical follow up. The purposes of this study are: 1: to validate the use of conventional planar bone scintigraphy and SPECT combined with low-dose or diagnostic CT and compare this to 3 Tesla MRI and clinical follow up. 2: to compare the specificity of low-dose and diagnostic CT, respectively, combined with bone SPECT. 3: to construct an algorithm for optimal evaluation of disease dissemination in breast cancer patients

Criteria for eligibility:

Study pop:
women aged 18-80 years with suspicision of disseminated breast cancer seen at Dept. of Oncology, Aarhus University Hospital

Sampling method: Probability Sample
Criteria:
Inclusion Criteria: - Histological verified breast cancer - Age 18-80 years - Investigation for metastases using imaging modality/modalities planned - Written consent to participate in trial Exclusion Criteria: - Overweight limiting the use of MRI - Metal parts in body - Claustrophobia - Allergy to contrast agents used in trial - Pregnancy

Gender: Female

Minimum age: 18 Years

Maximum age: 80 Years

Healthy volunteers: No

Locations:

Facility:
Name: Aarhus University Hospital

Address:
City: Aarhus
Zip: 8000
Country: Denmark

Status: Recruiting

Start date: May 2008

Completion date: March 2011

Lead sponsor:
Agency: University of Aarhus
Agency class: Other

Source: University of Aarhus

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT00682253

Login to your account

Did you forget your password?